Groupama Asset Managment Lowers Stock Holdings in Corteva, Inc. $CTVA

Groupama Asset Managment reduced its holdings in Corteva, Inc. (NYSE:CTVA) by 71.9% during the 1st quarter, Holdings Channel reports. The firm owned 5,025 shares of the company’s stock after selling 12,884 shares during the quarter. Groupama Asset Managment’s holdings in Corteva were worth $421,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Drummond Knight Asset Management Pty Ltd purchased a new position in Corteva in the 4th quarter valued at about $25,713,000. Arbejdsmarkedets Tillaegspension purchased a new stake in Corteva during the 4th quarter worth approximately $23,679,000. Leonteq Securities AG purchased a new stake in Corteva during the 4th quarter worth approximately $2,350,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Corteva by 23.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after acquiring an additional 20,957 shares during the last quarter. Finally, Brandes Investment Partners LP lifted its position in shares of Corteva by 1.1% in the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock valued at $155,009,000 after acquiring an additional 24,985 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Corteva reported second-quarter adjusted EPS of $2.30, exceeding the $2.24 analyst consensus and rising from $2.20 a year earlier. Seed pricing, productivity improvements, demand for newer genetics and traits, and growth in Crop Protection products supported margins. Reuters earnings report
• Positive Sentiment: The company raised its fiscal 2026 EPS outlook to $3.60-$3.80, reflecting strong first-half performance, operating improvements and growth platforms. Management also said it remains on track for the planned October 1 Vylor spin-off, a potential catalyst for improved business focus and valuation. Corteva first-half results and outlook
• Positive Sentiment: Analyst commentary remains broadly constructive: Corteva has outperformed the broader market and agriculture-focused ETFs, while brokerages maintain a consensus “Moderate Buy” rating. Momentum-focused analysis also highlights the company’s improving execution and fundamentals. Brokerage consensus rating
• Neutral Sentiment: Despite the earnings beat and higher guidance, one analysis argues that much of Corteva’s improved execution is already reflected in the stock, leaving limited upside unless earnings growth accelerates. Corteva valuation analysis
• Negative Sentiment: Second-quarter revenue was $6.38 billion, below the $6.60 billion consensus and down 1.2% year over year. The sales miss, together with competitive pricing pressure, appears to be the main reason the stock moved lower despite the profit beat and raised outlook. Corteva second-quarter earnings summary

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Morgan Stanley boosted their price target on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Bank of America raised their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Oppenheimer upped their target price on shares of Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, July 23rd. BNP Paribas Exane increased their target price on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Finally, Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $90.19.

Corteva Price Performance

Shares of CTVA stock opened at $78.98 on Monday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market capitalization of $52.83 billion, a PE ratio of 52.31, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. The firm’s 50-day moving average is $82.15 and its two-hundred day moving average is $79.63. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts predict that Corteva, Inc. will post 3.75 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio is presently 47.68%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.